HIVAIDSthrombocytopeniaantibodiestherapysplenectomyhighly active antiretrovirus therapВИЧСПИДтромбоцитопенияантителатерапияспленэктомиявысокоактивная антиретровирусная терапияидиопатическая тромбоцитопеническая пурпур1.Ratner L. HIV-1 associated thrombocytopenia. In: Aids Clinical Treatment Group Meeting. Internal. Conferens on AIDC July 1988. Washington, DC.2.Schneider P. A., Abrams D. I., Rayner A. A., Hohn D. С. Immunodeficiency associated thrombocytopenic purpura (IDTP). Arch. Surg. 1987; 122: 1175-1178.3.Bussel J. В., Haimi J. S. Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin. Am. J. Hematol. 1988; 28: 79-84.4.Mueller B. U. Hematological problems and their management in children with HIV infection. In: Pizzo P. A., Wilfert С. M., eds. Pediatric AIDS. Baltimore: Williams and Wilkins Publishers; 1994. 591-601.5.Ellaurie M., Burns E. R., Bernstein L. J. et al. Thrombocytopenia and human immunodeficiency virus in children. Pediatrics 1988; 82: 905.6.Jost J., Tauber M. G., Luthy R., Siegenthaler W. HIV-associated thrombocytopenia. Schweiz. Med. Wschr. 1988; 118: 206-212.7.Najean Y., Rain J. D. The mechanism of thrombocytopenia in patients with HIV. J. Lab. Clin. Med. 1994; 123: 415.8.Кравченко А. В. и др. Патогенетические механизмы нарушений системы гемостаза у больных ВИЧ-инфекцией. Эпидемиол. и инфекц. бол. 2000; 3: 45-49.9.Greco М., Karpatkin S. Complement-independent, peroxide induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 2001; 106: 551-561.10.Nardi M., Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J. Exp. Med. 2000; 191: 2093-2100.11.Cole J. L., Marzec U. M., Gunthel C. J. et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 1998; 91: 3239-3246.12.Ballem P., Belzberg A., Devine D. et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 1992; 327: 1779-1784.13.Heyns A. P., Badenhorst P. N., Lotter M. G. et al. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous In 111-labeled platelets and homologous 51Cr-labeled platelets differ. Blood 1986; 67: 86-92.14.Duedari G., Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 1992; 80: 162-169.15.Пивник А. В., Коровушкин В. Г., Пархоменко Ю. Г. и др. Дифференциальная диагностика лимфаденопатий при ВИЧ/СПИД. Тер. арх. 2006; 78 (4): 28-32.16.Landonio G., Nosari А. М., Spinelli F. et al. HIV-related thrombocytopenia: four different clinical subsets. Haematologica 1992; 77: 398-401.17.Glovanni E., Longo G., Luppi M. et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97 (3): 812-814.18.Michel A. et al. Immune thrombocytopenic purpura and Helicobacter pylori infection. Arch. Intern. Med. 2003; 163: 120-121.19.Morris L., Distenfeld A., Amorosi E., Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann. Intern. Med. 1982; 96: 714-717.20.Aboulafia D. M., Bundow D., Walde S. et al. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. Am. J. Med. Sci. 2000; 320: 117-123.21.Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP practice guideline panel. Ann. Intern. Med. 1997; 126: 319-326.22.Jubault V., Viard J. P. Worsening of HIV-1-related immune thrombocytopenia in patients receiving triple combination therapy. In: Int. Conf AIDS. 1998; 12: 551.23.Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS). Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV): a prospective study. Ann. Intern. Med. 1988; 109: 718-721.24.Landonio G., Nosari A., Spinelli F. HIV-related thrombocytopenia. N. Engl. J. Med. 1993; 328: 1785.25.Ananworanich J., Phamuphak N., Nuesch R. et al. Recurrent thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 2003; 37: 723-725.26.Marroni M., Gresele P., Landonio G. et al. Interferon-a is effective in the treatment of HIV-1 related, severe, zidovudine-resistant thrombocytopenia: a prospective, placebo-controlled, double-blind trial. Ann. Intern. Med. 1994; 121: 423-429.27.Vianelli N., Catani L., Gugliotta L. et al. Recombinant alpha-interferon 2b in the treatment of HIV related thrombocytopenia. AIDS 1993; 7: 823-827.28.Bussel J. В., Haimi J. S. Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gamma globulin. Am. J. Hematol. 1988; 28: 79-84.29.Oksenhendler E., Bierling P., Brossard Y. et al. Anti-Rh immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura. Blood 1988; 71: 1499-1502.30.Ferguson С. M. Splenectomy for immune thrombocytopenia related to human immunodeficiency virus. Surg. Gynecol. Obstet. 1988; 167: 300-302.31.Barbui Т., Cortelazzo S., Minetti B. et al. Does splenectomy enhance risk of AIDS in HIV-positive patients with chronic thrombocytopenia? Lancet 1987; 2: 342-343.32.Oksenhendler E., Bierling P., Chevret S. et al. Splenectomy is safe and effective in human immunodeficiency virus related immune thrombocytopenia. Blood 1993; 82: 29-32.33.Kemeny M. M., Cooke V., Melester T. S. et al. Splenectomy in patients with AIDS and AIDS-related complex. AIDS 1993; 7: 1063-1067.34.Lord R. V. N., Coleman M. J., Milliken S. T. Splenectomy for HIV-related immune thrombocytopenia: Comparison with results of splenectomy for non-HIV immune thrombocytopenic purpura. Arch. Surg. 1998; 133: 205-210.35.Harker L. A., Marzec U. M., Novembre F. et al. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor. Blood 1998; 91: 4427-4433.36.Cole J. L., Marzec U. M., Gunthel C. J. et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 1998; 91: 3239-3246.37.Marroni M., Gresele P., Landonio G. et al. Interferon a is effective in the treatment of HIV-1 related, severe, zidovudine-resistant thrombocytopenia. A prospective placebo-controlled double-blind trial. Ann. Intern. Med. 1994; 121: 423-429.38.Caso J. A. A., Mingo C. S., Tena J. G. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection. N. Engl. J. Med. 1999; 16 (16): 1239-1240.39.Marroni M., Gresele P., Landonio G. et al. Interferon-a is effective in the treatment of HIV-1 related, severe, zidovudine-resistant thrombocytopenia: a prospective, placebo-controlled, double-blind trial. Ann. Intern. Med. 1994; 121: 423-429.40.Brams P., Black A., Padlan E. A. et al. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40 mediated human В cell activation. Int. Immunopharmacol. 2001; 1: 277-294.41.Masataka Kuwana, Shosaku Nomura, Kingo Fujimura et al. Effect of a single injection of humanized anti-CD 154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura. Blood 2004; 103 (4): 1229-1236.42.Пивник А. В., Пархоменко Ю. Г., Криволапов Ю. А., Тишкевич О. А. Соматические проблемы ВИЧ-Медицины: СПИД-ассоциированные лимфомы. Онкогематология 2007; 3: 27-37.43.Волкова М. А., Бялик Т. Е. Ритуксимаб в терапии аутоиммунных осложнений при хроническом лимфолейкозе. Гематол. и трансфузиол. 2006; 3: 11-17.44.Cooper N., Stasi R., Cunningham-Rundles S. et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br. J. Haematol. 2004; 125: 232-239.45.Giagounidis A. A., Anhuf J., Schneider P. et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur. J. Haematol. 2002; 69: 95-100.46.Stasi R., Pagano A., Stipa Е., Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001; 98: 952-957.